Literature DB >> 27353685

The intersection between asthma and acute chest syndrome in children with sickle-cell anaemia.

Michael R DeBaun1, Robert C Strunk2.   

Abstract

Acute chest syndrome is a frequent cause of acute lung disease in children with sickle-cell disease. Asthma is common in children with sickle-cell disease and is associated with increased incidence of vaso-occlusive pain events, acute chest syndrome episodes, and earlier death. Risk factors for asthma exacerbation and an acute chest syndrome episode are similar, and both can present with shortness of breath, chest pain, cough, and wheezing. Despite overlapping risk factors and symptoms, an acute exacerbation of asthma or an episode of acute chest syndrome are two distinct entities that need disease-specific management strategies. Although understanding has increased about asthma as a comorbidity in sickle-cell disease and its effects on morbidity, substantial gaps remain in knowledge about best management.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27353685      PMCID: PMC5041533          DOI: 10.1016/S0140-6736(16)00145-8

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  58 in total

1.  Asthma is associated with acute chest syndrome, but not with an increased rate of hospitalization for pain among children in France with sickle cell anemia: a retrospective cohort study.

Authors:  Francoise Bernaudin; Robert C Strunk; Annie Kamdem; Cecile Arnaud; Ping An; Martine Torres; Christophe Delacourt; Michael R DeBaun
Journal:  Haematologica       Date:  2008-09-24       Impact factor: 9.941

2.  Relationships of race and socioeconomic status with prevalence, severity, and symptoms of asthma in Chicago school children.

Authors:  V W Persky; J Slezak; A Contreras; L Becker; E Hernandez; V Ramakrishnan; J Piorkowski
Journal:  Ann Allergy Asthma Immunol       Date:  1998-09       Impact factor: 6.347

3.  Airway hyperreactivity in children with sickle cell disease.

Authors:  M A Leong; C Dampier; L Varlotta; J L Allen
Journal:  J Pediatr       Date:  1997-08       Impact factor: 4.406

4.  "Acute chest syndrome" in adults with sickle cell anemia. Microbiology, treatment, and prevention.

Authors:  S Charache; J C Scott; P Charache
Journal:  Arch Intern Med       Date:  1979-01

5.  Recurrent, severe wheezing is associated with morbidity and mortality in adults with sickle cell disease.

Authors:  Robyn T Cohen; Anusha Madadi; Morey A Blinder; Michael R DeBaun; Robert C Strunk; Joshua J Field
Journal:  Am J Hematol       Date:  2011-08-02       Impact factor: 10.047

6.  Elevation of IgE in children with sickle cell disease is associated with doctor diagnosis of asthma and increased morbidity.

Authors:  Ping An; Emily A Barron-Casella; Robert C Strunk; Robert G Hamilton; James F Casella; Michael R DeBaun
Journal:  J Allergy Clin Immunol       Date:  2011-03-09       Impact factor: 10.793

7.  Heme oxygenase-1 gene promoter polymorphism is associated with reduced incidence of acute chest syndrome among children with sickle cell disease.

Authors:  Christopher J Bean; Sheree L Boulet; Dorothy Ellingsen; Meredith E Pyle; Emily A Barron-Casella; James F Casella; Amanda B Payne; Jennifer Driggers; Heidi A Trau; Genyan Yang; Kimberly Jones; Solomon F Ofori-Acquah; W Craig Hooper; Michael R DeBaun
Journal:  Blood       Date:  2012-09-10       Impact factor: 22.113

8.  Factors predicting future ACS episodes in children with sickle cell anemia.

Authors:  Michael R DeBaun; Mark Rodeghier; Robyn Cohen; Fenella J Kirkham; Carol L Rosen; Irene Roberts; Ben Cooper; Janet Stocks; Olu Wilkey; Baba Inusa; John O Warner; Robert C Strunk
Journal:  Am J Hematol       Date:  2014-08-27       Impact factor: 10.047

9.  Low forced expiratory volume is associated with earlier death in sickle cell anemia.

Authors:  Adetola A Kassim; Amanda B Payne; Mark Rodeghier; Eric A Macklin; Robert C Strunk; Michael R DeBaun
Journal:  Blood       Date:  2015-08-10       Impact factor: 22.113

10.  Wheezing symptoms and parental asthma are associated with a physician diagnosis of asthma in children with sickle cell anemia.

Authors:  Robert C Strunk; Robyn T Cohen; Benjamin P Cooper; Mark Rodeghier; Fenella J Kirkham; John O Warner; Janet Stocks; Jane Kirkby; Irene Roberts; Carol L Rosen; Daniel I Craven; Michael R DeBaun
Journal:  J Pediatr       Date:  2013-12-31       Impact factor: 4.406

View more
  16 in total

Review 1.  Measuring success: utility of biomarkers in sickle cell disease clinical trials and care.

Authors:  Ram Kalpatthi; Enrico M Novelli
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

Review 2.  Pathophysiology of Sickle Cell Disease.

Authors:  Prithu Sundd; Mark T Gladwin; Enrico M Novelli
Journal:  Annu Rev Pathol       Date:  2018-10-17       Impact factor: 23.472

3.  Asthma Screening in Pediatric Sickle Cell Disease: A Clinic-Based Program Using Questionnaires and Spirometry.

Authors:  Sara C Sadreameli; Rachel O Alade; Peter J Mogayzel; Sharon McGrath-Morrow; John J Strouse
Journal:  Pediatr Allergy Immunol Pulmonol       Date:  2017-12-01       Impact factor: 1.349

Review 4.  Placenta growth factor mediated gene regulation in sickle cell disease.

Authors:  Vijay K Kalra; Shuxiao Zhang; Punam Malik; Stanley M Tahara
Journal:  Blood Rev       Date:  2017-08-16       Impact factor: 8.250

5.  Aeroallergen sensitization predicts acute chest syndrome in children with sickle cell anaemia.

Authors:  Shaina M Willen; Mark Rodeghier; Robert C Strunk; Leonard B Bacharier; Carol L Rosen; Fenella J Kirkham; Michael R DeBaun; Robyn T Cohen
Journal:  Br J Haematol       Date:  2018-01-24       Impact factor: 6.998

6.  Developing new pharmacotherapeutic approaches to treating sickle-cell disease.

Authors:  Marilyn J Telen
Journal:  ISBT Sci Ser       Date:  2016-11-15

7.  Performance of ICD-10-CM diagnosis codes for identifying children with Sickle Cell Anemia.

Authors:  Sarah L Reeves; Brian Madden; Meng Wu; Lauren S Miller; David Anders; Michele Caggana; Lindsay W Cogan; Mary Kleyn; Isabel Hurden; Gary L Freed; Kevin J Dombkowski
Journal:  Health Serv Res       Date:  2020-01-09       Impact factor: 3.402

8.  Losartan for the nephropathy of sickle cell anemia: A phase-2, multicenter trial.

Authors:  Charles T Quinn; Santosh L Saraf; Victor R Gordeuk; Courtney D Fitzhugh; Susan E Creary; Prasad Bodas; Alex George; Ashok B Raj; Alecia C Nero; Catherine E Terrell; Lisa McCord; Adam Lane; Hans C Ackerman; Yu Yang; Omar Niss; Michael D Taylor; Prasad Devarajan; Punam Malik
Journal:  Am J Hematol       Date:  2017-07-19       Impact factor: 10.047

9.  Randomized phase 2 trial of monthly vitamin D to prevent respiratory complications in children with sickle cell disease.

Authors:  Margaret T Lee; Meyer Kattan; Ilene Fennoy; Stephen M Arpadi; Rachel L Miller; Serge Cremers; Donald J McMahon; Jeri W Nieves; Gary M Brittenham
Journal:  Blood Adv       Date:  2018-05-08

10.  Inhaled corticosteroid use to prevent severe vaso-occlusive episode recurrence in children between 1 and 4 years of age with sickle cell disease: a multicenter feasibility trial.

Authors:  Leah Vance Utset; Zalaya Ivy; Shaina M Willen; Mark Rodeghier; Amanda Watt; Leann Schilling; Chantel L Jenkins; Stefanie Pepper; Barbara Speller-Brown; Deepika S Darbari; Suvankar Majumdar; Olufolake Adisa; Michael R DeBaun
Journal:  Am J Hematol       Date:  2018-02-05       Impact factor: 10.047

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.